Empagliflozin and Left Atrial Function in Patients with Type 2 Diabetes Mellitus and Coronary Artery Disease: Insight from the EMPA-HEART CardioLink‐6 Randomized Clinical Trial
Cardiovascular Diabetology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined